Bionomics Limited Valuation
| BNOEFDelisted Stock | USD 0.01 0.00 0.00% |
Bionomics seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Bionomics Limited from analyzing the firm fundamentals such as Operating Margin of (2.91) %, return on equity of -0.42, and Shares Outstanding of 1.35 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bionomics' price fluctuation is very steady at this time. Calculation of the real value of Bionomics Limited is based on 3 months time horizon. Increasing Bionomics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bionomics pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Bionomics Limited. Since Bionomics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bionomics Pink Sheet. However, Bionomics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0131 | Real 0.0124 | Hype 0.01 |
The real value of Bionomics Pink Sheet, also known as its intrinsic value, is the underlying worth of Bionomics Limited Company, which is reflected in its stock price. It is based on Bionomics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bionomics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bionomics Limited helps investors to forecast how Bionomics pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bionomics more accurately as focusing exclusively on Bionomics' fundamentals will not take into account other important factors: Bionomics Total Value Analysis
Bionomics Limited is currently forecasted to have takeover price of 27.83 M with market capitalization of 29.11 M, debt of 693.62 K, and cash on hands of 33.56 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bionomics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
27.83 M | 29.11 M | 693.62 K | 33.56 M |
Bionomics Investor Information
About 49.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.24. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bionomics Limited recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. Based on the key indicators related to Bionomics' liquidity, profitability, solvency, and operating efficiency, Bionomics Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Bionomics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bionomics has an asset utilization ratio of 0.4 percent. This implies that the Company is making $0.004037 for each dollar of assets. An increasing asset utilization means that Bionomics Limited is more efficient with each dollar of assets it utilizes for everyday operations.Bionomics Ownership Allocation
Bionomics holds a total of 1.35 Billion outstanding shares. 30% of Bionomics Limited outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bionomics Profitability Analysis
The company reported the revenue of 263.63 K. Net Loss for the year was (21.76 M) with loss before overhead, payroll, taxes, and interest of (9.94 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bionomics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bionomics and how it compares across the competition.
About Bionomics Valuation
The pink sheet valuation mechanism determines Bionomics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Bionomics. We calculate exposure to Bionomics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bionomics's related companies.Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on OTC Exchange in the United States.
8 Steps to conduct Bionomics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bionomics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bionomics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bionomics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bionomics' revenue streams: Identify Bionomics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bionomics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bionomics' growth potential: Evaluate Bionomics' management, business model, and growth potential.
- Determine Bionomics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bionomics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bionomics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bionomics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.4 B | |
| Forward Price Earnings | 23.5849 | |
| Retained Earnings | -173.3 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |